...
首页> 外文期刊>Journal of Oncology Practice >Caution Ahead: Research Challenges of a Randomized Controlled Trial Implemented to Improve Breast Cancer Treatment at Safety-Net Hospitals
【24h】

Caution Ahead: Research Challenges of a Randomized Controlled Trial Implemented to Improve Breast Cancer Treatment at Safety-Net Hospitals

机译:提前警告:在Safety-Net医院实施随机对照试验以改善乳腺癌治疗的研究挑战

获取原文
           

摘要

Purpose: To implement and test a Web-based tracking and feedback (T&F) tool to close referral loops and reduce adjuvant breast cancer treatment underuse in safety-net hospitals (SNHs). Patient and Methods: We randomly assigned 10 SNHs, identified patients with new stage 1 to stage 3 breast cancer, assessed their connection with the oncologist, and relayed this information to surgeons for follow-up. We interviewed key informants about the tool’s usefulness. We conducted intention-to-treat and pre- and poststudy analyses to assess the T&F tool and implementation effectiveness, respectively. Results: Between the study start and intervention implementation, several hospitals reorganized care delivery and 49% of patients scheduled to undergo breast cancer surgery were ineligible because they already were in contact with an oncologist. One high-volume hospital closed. Despite randomization of hospitals, intervention (INT) hospitals had fewer white patients (5% v 16%; P = .0005), and more underuse (28% v 15%; P = .002) compared with usual care (UC) hospitals. Over time, INT hospitals with poorer follow-up significantly reduced underuse compared with UC hospitals (INT hospitals, from 33% to 9%, P = .001 v UC hospitals, from 15% to 11%, P = .5). There was no difference in underuse (9% at INT hospitals, 11% at UC hospitals; P = .8). Hospitals with better follow-up (odds ratio, 0.85; 95% CI, 0.73 to 0.98) had less underuse. In settings with poor follow-up and tracking approaches, key informants found the tool useful. The rapidly changing delivery landscape posed significant challenges to this implementation research. Conclusion: A T&F tool did not significantly reduce adjuvant underuse but may help reduce underuse in SNHs with poor follow-up capabilities. Inability to discern T&F effectiveness is likely due to encountered challenges that inform lessons for future implementation research.
机译:目的:实施和测试基于Web的跟踪和反馈(T&F)工具,以关闭转诊回路并减少安全网医院(SNHs)中使用不足的辅助性乳腺癌治疗。患者和方法:我们随机分配了10个SNH,确定了新的1期至3期乳腺癌患者,评估了他们与肿瘤科医生的联系,并将此信息传递给外科医生进行随访。我们就该工具的实用性采访了重要的信息提供者。我们进行了意向性处理和研究前和研究后分析,分别评估了T&F工具和实施效果。结果:从研究开始到实施干预之间,几家医院重新组织了医疗服务,并且计划进行乳腺癌手术的患者中有49%不符合条件,因为他们已经与肿瘤科医生进行了接触。一所大型医院关闭了。尽管医院是随机分配的,但与普通护理医院相比,介入治疗(INT)医院的白人患者较少(5%vs 16%; P = .0005),未充分利用的患者(28%vs 15%; P = 0.002) 。随着时间的推移,与UC医院相比,随访情况较差的INT医院的使用率显着降低(INT医院从33%降至9%,P = .001 v UC医院,从15%降至11%,P = .5)。未充分利用之间没有差异(INT医院为9%,UC医院为11%; P = 0.8)。随访较好的医院(优势比为0.85; 95%CI为0.73至0.98)使用率较低。在跟进和跟踪方法较差的环境中,关键信息提供者认为该工具很有用。快速变化的交付格局给实施研究提出了重大挑战。结论:T&F工具并不能显着减少辅助用药不足,但可以帮助减少随访能力较差的SNHs的用药不足。由于遇到的挑战可能无法识别T&F的有效性,这些挑战为将来的实施研究提供了经验教训。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号